Analyst Ratings for Dyne Therapeutics (DYN)
DYN Rating Summary
DYN Price Target Summary
- Highest: $50.00 (Jefferies)
- Lowest: $16.00 (JPMorgan)
- Average: $37.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$37.14 (+101.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$37.14 (+101.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/10/2025 | Oppenheimer | Jay Olson | Upgrade | Outperform (Perform) |
40.00 (11.00) |
18.44 (18.41) |
-0.16% | Details |
| 8/25/2025 | Raymond James » Updated 3/25/2026 |
Michael Freeman | Upgrade | Strong Buy (Outperform) |
40.00 (N/A) |
12.58 (18.41) |
46.34% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
